Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Aug 24, 2019 5:20 AM EDT Latest News August 23, 2019 Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration August 15, 2019 European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis August 9, 2019 China National Medical Products Administration Approves Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for Treatment of HIV-1 Infection View All Events Jul 30, 2019 at 4:30 PM EDT Second Quarter 2019 Gilead Sciences Earnings Conference Call Jul 14, 2019 at 3:00 PM EDT Gilead Sciences and Galapagos Global Collaboration Conference Call Jun 5, 2019 at 11:30 AM EDT Gilead Sciences at the Jefferies 2019 Healthcare Conference View All
